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RESULTS OF RE-EXCISION FOR INADEQUATE MARGINS FOLLOWING PARTIAL
MASTECTOMY FOR CARCINOMA OF THE BREAST
Aaron Bleznak, MD, FACS; Christine Du, MD; Samuel Steerman, MD; Elizabeth Dellers, MD
Lehigh Valley Health Network, Allentown, Pennsylvania

Objective:
To examine the incidence of residual disease in re-excisional
surgical specimens after breast conserving therapy (i.e.
lumpectomy) necessitating a second operation for positive and/or
close margins. According to the literature (Singh, 2010) , between
20-60% of patients treated with lumpectomy undergo a second
operation (either repeat lumpectomy or mastectomy) because of
inadequate margins. The frequency of re-excision varies because of
individual institutional definitions of what constitutes an acceptable
margin, with most centers preferring 1-3 mm as opposed to the
NSABP historical definition of no cancer cells on ink. (Singletary,
2002) Many patients who undergo a second operation have no
residual disease. (Frazier, 1989) Historically, our cancer program at
Lehigh Valley Health Network has required 2-3 mm margins free of
both invasive and noninvasive breast cancer and this is annually
reviewed and stated in our Breast Cancer Treatment Guidelines.
However, in specific circumstances and after multidisciplinary review
we accept less than 2 mm margins, particularly if the margin is
negative and there is minimal disease (usually DCIS) within 1-2 mm
of a single margin only. Our intent in this review was to determine
if we should redefine close and negative margins and if we could
identify those patients who do not have residual disease and do not
need a second operation by using margin distance to stratify risk of
residual disease.

Results:
Table 1. Findings at Re-excision
Number of Patients
Total
Number with Residual Disease
of Patients
on Re-excision

Margin
Invasive tumor at margin

19

4

Figure 1. Results of Re-excisions by Surgical Procedure
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Method:
Retrospective, single institution chart review of 95 patients who underwent a second
operation for positive and/or close margins from 2008-2009. Of those, 88 had
sufficient information in the pathology report to ascertain the distance of the invasive
or noninvasive carcinoma from the margins. Patients were considered to have
residual disease only if the re-excision specimen contained invasive or noninvasive
cancer; atypical hyperplasia and lobular neoplasia (LCIS) were considered benign.
Data collected included the histologic subtype of cancer, distance of tumor from the
margin(s) of the initial specimen and the presence of residual disease in the re-excision
specimen. Pathologic evaluation was performed by two breast pathologists.
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Conclusion:
In this 2 year retrospective review, re-excisional specimens
revealed residual cancer in 21-33% of cases with margins
that were involved or negative but < 2 mm. This study
is limited by a lack of power, absence of information on
the extent of disease at the closest margin, and probable
selection bias.
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